Monday, June 29, 2020 4:53:24 PM
raf@ I have followed Fauci's WAR 'to avoid'- following Didier Rault 'early solution'.
The HCQ treatment was far to cheap - and did not 'make the most of this 'worst pandemic crises' - for WHO and Bio Power people - who saw/see this as maybe 'the biggest chance in their lifetime' - to make Real Money on Vaccine and NEW treatments like Remdesivir (that already long ago proved to sadly be a waste of money and time).
---------------------
The solution - HCQ - have been here right from the start - and Front Line Doctors do now actually Prove it (via the backdoor you might say) - but the numbers of Trials in Hydroxychloroquine stil rising - now 230 - who wants to waste time (and an awful lot of money) on Remdesiwir - that 'at best' cuts of a few days of the patients that would not die anyway.
The treatment cause you mention is sadly PROFE of how corrupt Fauci and CDC is' (with now tens of thousands of lifes on their consion) rejecting the logic/cheap solution of using the old malariadrug HCQ.
Truth is' - that in Real World (not Fauci's fancy conferences 'all the time talking UP the pandemic) - but in 'Real World hospitals around the world - doctors now 'Everywhere' have experienced What Works' - HCQ and Antibiotics - given as early as possible.
https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=Hydroxychloroquine&cntry=&state=&city=&dist=&Search=Search
Jasbg
NB: Remdesivir trials (through presseure) and stil not many - compared to the treatment 'that now does make number of deaths fall' - even the number of infected rises.
https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=Remdesivir&cntry=&state=&city=&dist=&Search=Search
Talksense covering HCQ (translate bottom right):
http://talksense.dk/category/fnmonster/corona
The HCQ treatment was far to cheap - and did not 'make the most of this 'worst pandemic crises' - for WHO and Bio Power people - who saw/see this as maybe 'the biggest chance in their lifetime' - to make Real Money on Vaccine and NEW treatments like Remdesivir (that already long ago proved to sadly be a waste of money and time).
---------------------
The solution - HCQ - have been here right from the start - and Front Line Doctors do now actually Prove it (via the backdoor you might say) - but the numbers of Trials in Hydroxychloroquine stil rising - now 230 - who wants to waste time (and an awful lot of money) on Remdesiwir - that 'at best' cuts of a few days of the patients that would not die anyway.
The treatment cause you mention is sadly PROFE of how corrupt Fauci and CDC is' (with now tens of thousands of lifes on their consion) rejecting the logic/cheap solution of using the old malariadrug HCQ.
Truth is' - that in Real World (not Fauci's fancy conferences 'all the time talking UP the pandemic) - but in 'Real World hospitals around the world - doctors now 'Everywhere' have experienced What Works' - HCQ and Antibiotics - given as early as possible.
https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=Hydroxychloroquine&cntry=&state=&city=&dist=&Search=Search
Jasbg
NB: Remdesivir trials (through presseure) and stil not many - compared to the treatment 'that now does make number of deaths fall' - even the number of infected rises.
https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=Remdesivir&cntry=&state=&city=&dist=&Search=Search
Talksense covering HCQ (translate bottom right):
http://talksense.dk/category/fnmonster/corona
Recent AMRN News
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
